Skip to main content

Paion AG reports progress with BYFAVO(TM) (remimazolam) by its licensee Acacia in the U.S.

Written by Petra Hegmann on . Posted in Client News.

[image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″]